The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

barricaid.com

Founded Year

2000

Stage

Unattributed | Alive

Total Raised

$268.67M

Last Raised

$38.44M | 1 yr ago

About Intrinsic Therapeutics

Intrinsic Therapeutics is a medical device company focused on delivering a safe treatment to improve outcomes in patients who are at a disproportionately high risk of requiring repeat surgeries due to reherniation following lumbar discectomy surgery.

Intrinsic Therapeutics Headquarter Location

30 Commerce Way

Woburn, Massachusetts, 01801,

United States

781-932-0222

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Intrinsic Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Intrinsic Therapeutics is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,208 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,900 items

Intrinsic Therapeutics Patents

Intrinsic Therapeutics has filed 37 patents.

The 3 most popular patent topics include:

  • Bones of the vertebral column
  • Dosage forms
  • Drug delivery devices
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/8/2019

11/30/2021

Bones of the vertebral column, Medical equipment, Dosage forms, Drug delivery devices, Implants (medicine)

Grant

Application Date

11/8/2019

Grant Date

11/30/2021

Title

Related Topics

Bones of the vertebral column, Medical equipment, Dosage forms, Drug delivery devices, Implants (medicine)

Status

Grant

Latest Intrinsic Therapeutics News

Synlogic appoints Michael Jensen as CFO

Mar 3, 2022

Synlogic (NASDAQ: SYBX ) has appointed  Michael Jensen as CFO. Mr. Jensen, most recently served as the CFO at Intrinsic Therapeutics, a commercial-stage medical device company focused on delivering treatments to improve surgical efficacy. To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Intrinsic Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Intrinsic Therapeutics Rank

You May Also Like

O
OrthoMimetics

OrthoMimetics aiming to bring to market a line of products for the regenerative repair of cartilage, ligament and tendon injuries.

H
Haemechanics

Haemechanics has developed a synthetic, hemostatic material capable of simultaneously inducing blood clotting and delivering therapeutics. The material is able to induce clotting as effectively as biologically based products, at a fraction of the price.

P
Proneuron Biotechnologies

Biopharmaceutical products for the of spinal cord injuries and other central nervous system disorders.

N
NDO Surgical

Medical devices for the treatment of severe gastrointestinal disorders

V
Vitreo Retinal Technologies

Vitreo Retinal Technologies, Inc. is developing therapeutics for the treatment of serious ocular diseases.

Matrix Genomics Logo
Matrix Genomics

aims to provide customized genetic assessments of inherited susceptibility to age-related disorders.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.